Warner Chilcott
Ovcon
 

OVCON® 35 is an oral contraceptive, indicated for the prevention of pregnancy in women who choose to use this product as a means of contraception. A monthly supply of OVCONŽ 35 contains 21 pills that contain active ingredients, followed by 7 pills that are inactive. The active tablets contain 0.4 mg norethindrone and 35 mcg ethinyl estradiol.

Please note that two package types are currently available on the market, a compact and a credit card (blister card)

OVCON® 35 package contains 21 round, peach tablets of 0.4 mg norethindrone and 0.035 mg ethinyl estradiol, imprinted with MJ on one side and 583 on the other. Each of the 7 capsule shaped, green tablets contain inert ingredients and is imprinted with MJ on one side and 850 on the other. (NDC 0430-0582-14) Link to Full PI for Compact here.

Ovcon® 35 in the credit card (blister card) package contains 21 light peach, round, flatfaced, beveled-edge, unscored tablet, debossed with WC on one side and 580 on the other side. Each 7 white, capsule -shaped, biconvex tablet, debossed with WC on one side and 781 on the other side. (NDC 0430-0580-14) Link to Full PI for Credit Card here.

Patients taking OVCON® 35 experience minimal side effects.

  • Low incidence of breakthrough bleeding and spotting1
  • No weight change (either gain or loss) was documented in 99% of patients (over 20,000 cycles)2
Oral contraceptives offer noncontraceptive health benefits. During the time that women are taking combination oral contraceptives, many may experience the following improvements in their periods and health profiles:
  • Increased menstrual regularity
  • Less cramping
  • Decreased blood loss and decreased iron deficiency anemia
  • Decreased risk of getting endometrial cancer, or ovarian cancer

IMPORTANT SAFETY INFORMATION
Risks with OvconŽ 35 are similar to those with all birth control pills. Most side effects are not serious and those that are occur infrequently. Serious risks, which can be life threatening, include blood clots, stroke and heart attacks, and are increased if you smoke cigarettes. Cigarette smoking increases the risk of serious cardiovascular side effects, especially if you're over 35. Women who use oral contraceptives are strongly advised not to smoke. You should speak to your doctor or health care professional about how this risk relates to your use of the Pill. Some women should not use the Pill, including women who have or have had blood clots, certain cancers, a history of heart attack or stroke, as well as those who are or may be pregnant. Oral Contraceptives do not protect against HIV infection (AIDS) and other sexually transmitted diseases.

Patients using oral contraceptives may report the following drug-related side effects: nausea, vomiting, abdominal cramps and/or bloating, breast tenderness, headache, vaginal candidiasis, intolerance to contact lenses.

U.S. Prescribing Information
compact
credit card
 


Follow directions and take your pill every day
Users of OVCON 35® should read their package inserts carefully, and discuss oral contraceptive use with their healthcare practitioners. Women should learn what to do if they miss a pill. Please see Full Prescribing Information for specific patient instructions.
 
References: 1. Rudel HW, Maqueo M, Calderone J, Manatou JM. Safety and effectiveness of a new low-dose oral contraceptive: a three-year study of 1,000 women. J Reprod Med. 1978;21(2):79-88. 2. Data on file, Warner Chilcott, Inc.

Close Window
  
The product information provided in this site is intended only for residents of the United States.
The products discussed herein may have different product labeling in different countries.
The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider.
Decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient.